UA83094C2 - Tablet of citalopram hydrobromide - Google Patents
Tablet of citalopram hydrobromideInfo
- Publication number
- UA83094C2 UA83094C2 UAA200607053A UAA200607053A UA83094C2 UA 83094 C2 UA83094 C2 UA 83094C2 UA A200607053 A UAA200607053 A UA A200607053A UA A200607053 A UAA200607053 A UA A200607053A UA 83094 C2 UA83094 C2 UA 83094C2
- Authority
- UA
- Ukraine
- Prior art keywords
- tablet
- citalopram hydrobromide
- tablets
- preparation
- particle size
- Prior art date
Links
- WIHMBLDNRMIGDW-UHFFFAOYSA-N 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3h-2-benzofuran-5-carbonitrile;hydron;bromide Chemical compound [Br-].O1CC2=CC(C#N)=CC=C2C1(CCC[NH+](C)C)C1=CC=C(F)C=C1 WIHMBLDNRMIGDW-UHFFFAOYSA-N 0.000 title abstract 2
- 229960000584 citalopram hydrobromide Drugs 0.000 title abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- 239000003826 tablet Substances 0.000 abstract 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000007941 film coated tablet Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract 1
- 239000008108 microcrystalline cellulose Substances 0.000 abstract 1
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to tablets and film-coated tablets containing as active ingredient citalopram hydrobromide having a median particle size of less than 40 pm in admixture with microcrystalline cellulose having a median particle size in the range of 90 250 urn and other excipients conventionally applied for the preparation of tablets 1 he invention also provides a process for the preparation thereof.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0303790A HU227491B1 (en) | 2003-11-25 | 2003-11-25 | Tablet containing citalopram hydrogen bromide |
Publications (1)
Publication Number | Publication Date |
---|---|
UA83094C2 true UA83094C2 (en) | 2008-06-10 |
Family
ID=89981808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200607053A UA83094C2 (en) | 2003-11-25 | 2004-11-24 | Tablet of citalopram hydrobromide |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1694321A1 (en) |
BG (1) | BG109587A (en) |
CZ (1) | CZ2006376A3 (en) |
EA (1) | EA010290B1 (en) |
HU (1) | HU227491B1 (en) |
PL (1) | PL379864A1 (en) |
SK (1) | SK50532006A3 (en) |
UA (1) | UA83094C2 (en) |
WO (1) | WO2005051374A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI347942B (en) * | 2005-06-22 | 2011-09-01 | Lundbeck & Co As H | Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6607751B1 (en) * | 1997-10-10 | 2003-08-19 | Intellipharamaceutics Corp. | Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum |
IS6021A (en) * | 2000-08-10 | 2001-10-20 | H. Lundbeck A/S | Pharmaceutical formulations containing citalopram |
AU2001100195B4 (en) * | 2001-01-05 | 2001-12-20 | H Lundbeck As | Pharmaceutical composition containing citalopram. |
-
2003
- 2003-11-25 HU HU0303790A patent/HU227491B1/en unknown
-
2004
- 2004-11-24 EA EA200600932A patent/EA010290B1/en not_active IP Right Cessation
- 2004-11-24 WO PCT/HU2004/000110 patent/WO2005051374A1/en active Application Filing
- 2004-11-24 EP EP04798748A patent/EP1694321A1/en not_active Withdrawn
- 2004-11-24 UA UAA200607053A patent/UA83094C2/en unknown
- 2004-11-24 CZ CZ20060376A patent/CZ2006376A3/en unknown
- 2004-11-24 PL PL379864A patent/PL379864A1/en not_active Application Discontinuation
- 2004-11-24 SK SK5053-2006A patent/SK50532006A3/en not_active Application Discontinuation
-
2006
- 2006-06-23 BG BG109587A patent/BG109587A/en unknown
Also Published As
Publication number | Publication date |
---|---|
HU227491B1 (en) | 2011-07-28 |
PL379864A1 (en) | 2006-11-27 |
HUP0303790A2 (en) | 2005-08-29 |
WO2005051374A1 (en) | 2005-06-09 |
BG109587A (en) | 2006-12-29 |
SK50532006A3 (en) | 2006-09-07 |
HU0303790D0 (en) | 2004-03-01 |
CZ2006376A3 (en) | 2006-10-11 |
HUP0303790A3 (en) | 2005-09-28 |
EP1694321A1 (en) | 2006-08-30 |
EA010290B1 (en) | 2008-08-29 |
EA200600932A1 (en) | 2006-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1073263A1 (en) | A process for the preparation of tablets from pharmaceutically active substances having unfavourabletabletting properties with a granulating liquid c omprising microcrystalline cellulose | |
AU2003274681A1 (en) | Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release | |
AU2003297260A1 (en) | Fast-disintegrating solid dosage forms being not friable and comprising pullulan | |
CA2322315A1 (en) | Fast disintegrating tablets | |
WO2004000197A3 (en) | Quick dissolve compositions and tablets based thereon | |
CA2433585A1 (en) | Pharmaceutical compositions containing donepezil hydrochloride | |
CA2489407A1 (en) | Lasofoxifene tablet and its coating | |
TWI264311B (en) | Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency | |
BG104397A (en) | Extended release formulation | |
MY127350A (en) | Flash-melt oral dose formulations | |
EA201001108A1 (en) | TABLETS DISPENSABLE IN THE Mouth OF THE TABLET, CONTAINING THE BASIS OF THE ESCITALOPRAM, AND METHOD OF THEIR RECEIVING | |
WO2003059329A3 (en) | Polytartrate composition | |
MXPA06000332A (en) | Novel solid pharmaceutical composition comprising amisulpride. | |
WO2005115346A3 (en) | Pharmaceutical composition containing risperidone | |
NO20054417L (en) | Process for the preparation of pharmaceutical preparations in the form of fibrate-containing tablets and the tablets thus prepared | |
TW201129386A (en) | Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients | |
WO2004000265A3 (en) | Process for the preparation of robust formulations of valacyclovir hydrochloride tablets | |
UA89349C2 (en) | Uncoated tablet containing olanzapine and a process for preparing thereof | |
UA83094C2 (en) | Tablet of citalopram hydrobromide | |
UA97355C2 (en) | Pharmaceutical composition containing montelukast | |
BG108686A (en) | Cytisine-containing medicamentous form | |
LT2004062A (en) | Amlodipine bezylate tablets with improved stability | |
BRPI0211439B8 (en) | ||
PL1499278T3 (en) | Immediate-release pharmaceutical dosage form comprising polymorphous tibolone | |
AU4137300A (en) | Stable solid pharmaceutical compositions containing enalapril maleate |